These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10443472)

  • 41. The role of plasminogen in cell-mediated collagen degradation.
    Gavrilovic J; Murphy G
    Cell Biol Int Rep; 1989 Apr; 13(4):367-75. PubMed ID: 2731232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
    Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells.
    Lee E; Vaughan DE; Parikh SH; Grodzinsky AJ; Libby P; Lark MW; Lee RT
    Circ Res; 1996 Jan; 78(1):44-9. PubMed ID: 8603504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.
    Hui W; Rowan AD; Richards CD; Cawston TE
    Arthritis Rheum; 2003 Dec; 48(12):3404-18. PubMed ID: 14673992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures.
    Xu C; Oyajobi BO; Frazer A; Kozaci LD; Russell RG; Hollander AP
    Endocrinology; 1996 Aug; 137(8):3557-65. PubMed ID: 8754787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assays of proteoglycan and collagen degradation in cultures of rabbit cartilage explants.
    Lesur C; Sabatini M
    Methods Mol Med; 2004; 100():219-36. PubMed ID: 15280598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
    Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
    Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines.
    Koshy PJ; Henderson N; Logan C; Life PF; Cawston TE; Rowan AD
    Ann Rheum Dis; 2002 Aug; 61(8):704-13. PubMed ID: 12117676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism.
    Sztrolovics R; White RJ; Poole AR; Mort JS; Roughley PJ
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):571-7. PubMed ID: 10215595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes.
    Hui A; Min WX; Tang J; Cruz TF
    Arthritis Rheum; 1998 May; 41(5):869-76. PubMed ID: 9588740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
    Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
    Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes.
    Ahmed S; Wang N; Lalonde M; Goldberg VM; Haqqi TM
    J Pharmacol Exp Ther; 2004 Feb; 308(2):767-73. PubMed ID: 14600251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ivabradine abrogates TNF-α-induced degradation of articular cartilage matrix.
    Xiang X; Zhou Y; Sun H; Tan S; Lu Z; Huang L; Wang W
    Int Immunopharmacol; 2019 Jan; 66():347-353. PubMed ID: 30521963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis.
    Sundman EA; Cole BJ; Karas V; Della Valle C; Tetreault MW; Mohammed HO; Fortier LA
    Am J Sports Med; 2014 Jan; 42(1):35-41. PubMed ID: 24192391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of cartilage matrix metalloproteinases by activated protein C.
    Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
    Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition by a selective IkappaB kinase-2 inhibitor of interleukin-1-induced collagen degradation by corneal fibroblasts in three-dimensional culture.
    Kondo Y; Fukuda K; Adachi T; Nishida T
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4850-7. PubMed ID: 18676628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis.
    Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS
    Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model.
    Choi JH; Choi JH; Kim DY; Yoon JH; Youn HY; Yi JB; Rhee HI; Ryu KH; Jung K; Han CK; Kwak WJ; Cho YB
    Osteoarthritis Cartilage; 2002 Jun; 10(6):471-8. PubMed ID: 12056850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunological detection of type II collagen degradation: use in the evaluation of anti-arthritic therapies.
    Chichester CO; Barrach HJ; Srinivas GR; Mitchell P
    J Pharm Pharmacol; 1996 Jul; 48(7):694-8. PubMed ID: 8866331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.